Clinical trial
Prospective Registry of EoSinophilic esOphagitis (PRESO)
NCT06443346 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Registry of EoSinophilic esOphagitis (PRESO)
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 1, 2024
- Completion date
- December 31, 2044
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.